Selena Gomez has been through a lot since she entered the spotlight, and now more than ever, people can’t help but notice how ...

Objective Small fibre neuropathy (SFN) is an under-recognised complication of SLE that contributes to chronic pain and ...

Emily Henders received her CAR T last week at University College London Hospital (UCLH) as part of a global clinical trial ...

For years, life-changing treatments for rheumatic diseases remained out of reach for most Bangladeshis. Today, local innovation and medical leadership are rewriting that story — bringing hope, dignity ...

A biology teacher and mother-of-two has become the first patient in the UK to receive a “gamechanger” therapy to treat multiple sclerosis (MS). MS is a condition that affects the brain and spinal cord ...

Background Mixed connective tissue disease (MCTD) has long been debated as an early nonspecific phase/symptom of ...

Many of the tips for alleviating menopause symptoms can improve PsA symptoms, too, including exercise, stress management, and healthy nutrition. Avoiding processed foods, alcohol, and personal ...

The Rheumatology Initiative (tRi) has unveiled a groundbreaking digital health innovation — RheumaConnect, a mobile app set ...

The FDA has approved Gazyva (obinutuzumab) for the treatment of adult patients with active lupus nephritis who are receiving standard therapy.

Investigators employed the Accelerating Medicines Partnership to identify noninvasive biomarkers of lupus nephritis pathology and treatment response.

Background Lupus nephritis (LN) is the most serious complication of SLE. Interstitial fibrosis is the dominant pathological ...

Autoimmune neuromuscular diseases may sound complex, but understanding them is the first step to getting the right care and ...